ArticleCancer management and research2022

Case Report: First-Line Immune Checkpoint Inhibitor Plus Chemotherapy for Oral Metastasis in a Patient with Ultra High-Risk Gestational Choriocarcinoma.

Yu Chen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.